REQUEST A DEMO
Total
USD $0.00
Search more companies

Sopharmacy 20 EOOD (Софармаси 20 ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Sopharmacy 20 EOOD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sopharmacy 20 EOOD (Софармаси 20 ЕООД) is a company based in Bulgaria, with its head office in Sofia. It operates in the Pharmacies and Drug Stores sector. It was first established on August 23, 2007. 39 (2024) employees currently work for Sopharmacy 20 EOOD (Софармаси 20 ЕООД). In 2024, the company reported a net sales revenue increase of 24.54%. Its’ total assets recorded a growth of 3.36%. Sopharmacy 20 EOOD (Софармаси 20 ЕООД)’s net profit margin decreased by 0.44% in 2024.

Headquarters
Iztok, Bul./Ul. Lachezar Stanchev 5, Sofarma Biznes Tauars, Sgrada A, ET. 13
Sofia; Sofia - city; Postal Code: 1756

Contact Details: Purchase the Sopharmacy 20 EOOD (Софармаси 20 ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Sopharmacy 20 EOOD (Софармаси 20 ЕООД) report to view the information.
Registered Capital:
Purchase the Sopharmacy 20 EOOD (Софармаси 20 ЕООД) report to view the information.
Financial Auditors:
Purchase the Sopharmacy 20 EOOD (Софармаси 20 ЕООД) report to view the information.
Incorporation Date:
August 23, 2007
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sopharmacy 20 EOOD (Софармаси 20 ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
24.54%
Total Operating Revenue
25%
Operating Profit
14.55%
EBITDA
15.89%
Net Profit/Loss for the Period
16.98%
Total Assets
3.36%
Total Equity
0.95%
Operating Profit Margin
-0.51%
Net Profit Margin
-0.44%
Return on Equity (ROE)
15.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?